Stimulation of local antibody production: Parenteral or mucosal vaccination?

Trends in Immunology

Volumn 23, Issue 4, 2002, Pages 209-213

  Bouvet, Jean Pierre ^a   Decroix, Nipa ^a   Pamonsinlapatham, Perayot ^a  

^a HÔPITAL BROUSSAIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM POTASSIUM SULFATE; ANTIGEN; CALCITRIOL; CHOLERA TOXIN B SUBUNIT; DIPHTHERIA TOXOID; DNA VACCINE; EQUINE VIRUS VACCINE; ESCHERICHIA COLI ENTEROTOXIN; FORSKOLIN; HAEMOPHILUS INFLUENZAE VACCINE; HAPTEN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; INACTIVATED VACCINE; INFLUENZA VACCINE; INTERLEUKIN 12; LIVE VACCINE; OLIGODEOXYNUCLEOTIDE; ORAL POLIOMYELITIS VACCINE; PAPILLOMA VIRUS LIKE PARTICLE VACCINE; PERTUSSIS TOXIN; RETROVIRUS VACCINE; SECRETORY IMMUNOGLOBULIN; TETANUS TOXOID; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIGEN PRESENTING CELL; CELL ACTIVATION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; GENETIC RECOMBINATION; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; MUCOSA; MUCOSAL IMMUNITY; NONHUMAN; PATHOGENICITY; REVIEW; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; BACTERIAL VACCINES; HUMANS; IMMUNITY, ACTIVE; IMMUNITY, MUCOSAL; MODELS, IMMUNOLOGICAL; MUCOUS MEMBRANE; VACCINATION; VACCINES; VACCINES, INACTIVATED; VIRAL VACCINES;

EID: 0036533644     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4906(02)02186-5     Document Type: Review

References (53)

1. The specific patterns of human immunoglobulin G antibodies in serum differ from those in autologous secretions
2. Diversity of antibody-mediated immunity at the mucosal immune barrier
3. The B-cell system of human mucosae and exocrine glands
4. A three-tiered view of the role of IgA in mucosal defense
5. Biological significance of IgA1 proteases in bacterial colonization and pathogenesis: Critical evaluation of experimental evidence
6. Nonimmune macromolecular complexes of Ig in human gut lumen
7. Epithelial M cells: Differentiation and function
8. Compartmentalization within the common mucosal immune system
9. Regional specialization in the mucosal immune system: Primed cells do not always home along the same tract
10. Natural polyreactive secretory immunoglobulin A autoantibodies as a possible barrier to infections in humans
11. Naturally occurring antibodies against nine common antigens in human sera. I. Detection, isolation and characterization
12. Naturally occurring antibodies against nine common antigens in human sera. II. High incidence of monoclonal Ig exhibiting antibody activity against actin and tubulin and sharing antibody specificities with natural antibodies
13. From natural polyreactive autoantibodies to à la carte monoreactive antibodies to infectious agents: Is it a small world after all?
14. Résistance anti-bactérienne conférée par injection d'un liquide d'ascite (au moins partiellement débarassé d'IgM) et d'anticorps naturels monoclonaux d'origine humaine chez la truite arc-en-ciel
15. Control of early viral and bacterial distribution and disease by natural antibodies
16. Contribution of plasma-derived molecules to mucosal immune defence, disease and repair in the airways
17. High-affinity, serum-derived Fab fragments as another source of antibodies in the gut lumen of both neonates and adults
18. Neutralization of animal viruses
19. Bidirectional FcRn-dependent IgG transport in a polymerized human intestinal cell line
20. Mucosal immunity and tolerance: Relevance to vaccine development
21. Biodegradable microparticles as oral vaccines
22. A controlled clinical study of the effect of nasal immunization with a Streptocccus mutans antigen alone or incorporated into liposomes on induction of immune responses
23. Immune stimulating complexes as mucosal vaccines
24. Recombinant Norwalk virus-like particles given orally to volunteers: Phase I study
25. Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins
26. Mucosal vaccines: Non toxic derivatives of LT and CT as mucosal adjuvants
27. Intestinal and systemic immune responses in humans after oral immunization with a bivalent B subunit-O1/O139 whole cholera vaccine
28. Cost of immunization with a locally produced, oral cholera vaccine in Vietnam
29. Intranasal immunization with CPG oligonucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in the genital tract
30. IL-12 is an effective adjuvant for induction of mucosal immunity
31. Local antibody response to poliovaccine in the human female genital tract
32. Salivary antibody responses to oral and parenteral vaccines in children
33. Immunization of humans with polysaccharide vaccines induces systemic, predominantly polymeric IgA2-subclass antibody responses
34. Immunoglobulin G antibodies in human vaginal secretions after parenteral vaccination
35. Human immune responses to influenza virus vaccines administered by systemic or mucosal routes
36. Parenteral influenza vaccination induces a rapid systemic and local immune response
37. The induction of systemic and mucosal immune responses following the subcutaneous immunization of mature adult mice: Characterization of the antibodies in mucosal secretions of animals immunized with antigen formulations containing a vitamin D3 adjuvant
38. Induction in mucosa of IgG and IgA antibodies against parenterally administered soluble immunogens
39. The induction of systemic and mucosal immune responses to antigen-adjuvant compositions administered into the skin: Alterations in the migratory properties of dendritic cells appear to be important for stimulating mucosal immunity
40. Induction of virus-specific antibody production by lamina-propria lymphocytes following intramuscular inoculation with rotavirus
41. Immunologic correlates of protection against rotavirus challenge after intramuscular immunization of mice
42. Mucosa immunisation with papilloma virus-like particles elicits systemic and mucosal immunity in mice
43. Mucosal immunity induced by parenteral immunization with a live attenuated Venezuelan equine encephalitis virus vaccine candidate
44. DNA vaccines: Protective immunizations by parenteral, mucosal and gene-gun inoculations
45. Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge
46. Transcutaneous immunization induces mucosal and systemic immunity: A potent method for targeting immunity to the female reproductive tract
47. Immunization onto bare skin with heat-labile enterotoxin of Escherichia coli enhances immune responses to coadministered protein and peptide antigens and protects mice against lethal toxin challenge
48. The bare skin and the nose as non-invasive routes for administering peptide vaccines
49. Transcutaneous immunization: A human vaccine delivery strategy using a patch
50. Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques
51. Dendritic cell vaccination protects mice against lethality caused by genital herpes simplex virus type 2 infection
52. Migration of antigen-presenting B cells from peripheral to mucosal lymphoid tissues may induce intestinal antigen-specific IgA following parenteral immunization
53. Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization